main content start

Homepage

Our Login / Registration service is temporarily unavailable, due to technical issue.

Latest Videos

Latest Videos

Breast Cancer

Prostate Cancer

Multiple Myeloma

Multiple Myeloma

Brightcove Cards Listing

Popular on MedEnrich

Popular in No name
  • Breast Cancer3m 2s

    ESR1 Mutation as an emerging clinical biomarker metastatic hormone receptor positive Breast Cancer

    Combination of CDK4/6 inhibitors & aromatase inhibitor is recommended for frontline treatment of Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Patients eventually develop disease progression which might be attributed to ESR1 mutations.
    biomarkers esr1 mutation fulvestrant hormone receptor positive mbc serd
  • Breast Cancer14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • Myelodysplastic Syndromes8m 45s

    Current Challenges in MDS Diagnosis and Consequences

    Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
    non invasive mds diagnosis web based mds diagnosis tools
  • Prostate Cancer7m 6s

    Treating Metastatic Hormone Refractory Prostate Cancer - My Approach

    Revised definition of Castration Resistant Prostate Cancer (mCRPC) considers castration range testosterone with either biochemical progression with three consecutive rises in PSA or evidence of radiological progression.
    castration resistance mcrpc metastatic prostate cancer prostate cancer
  • Breast Cancer1m 21s

    Recent advances in triple-negative breast cancer (TNBC)

    Metastatic Triple Negative Breast Cancer is still an unmet medical need.
    germline brca mutation pdl1 triple negative breast cancer
  • OncoSpecials2m 41s

    Low Dose Dasatinib Ready For Clinical Practice

    Several studies carried out by institutions of repute have shown that Dasatinib 50 mg is as effective as 100 mg with less side effects.
    low dose dasatinib dasatinib 50mg
  • Prostate Cancer49m 18s

    Dissecting the biology of advanced prostate cancer

    Advanced prostate cancer is characterized by intricate biological changes, including genetic and epigenetic alterations, as well as shifts in cellular metabolism.
    advanced prostate cancer cellular metabolism castration-resistant prostate cancer targeted therapies improved patient care
  • Breast Cancer11m 14s

    Oral Selective Estrogen Receptor Degraders for ESR-1 Mutant Metastatic Breast Cancer

    Endocrine therapy is the mainstay in the management of patients with Hormone receptor positive (ER+ve) Metastatic Breast Cancer. Tumor progression in ER+ve MBC could be attributed to genomic alterations such as ESR mutations.
    biomarkers esr1 mutation fulvestrant hormone receptor positive mbc serd
  • OncoSpecials7m 52s

    Treatment Free Remission in CML - Ready for Prime Time

    TFR strategy is generally safe with adequate monitoring. Restarting TKI after loss of Major Molecular Response is safe with 80% of patients regaining MR4 after restarting TKI treatment.
    treatment free remission tfr dasatinib
  • Pharmacy37m 20s

    Quality management systems in pharmacy practice

    Dr Scott Soefje, PharmD, Mayo Clinic
    Provides a perspective “Quality Management Systems in Pharmacy Practice”.
    mednrich
  • For Pharmacist

    For Pharmacist

    Brightcove Cards Listing

    Webinars

    Webinar Cards Listing

    Upcoming Webinar

    Upcoming Webinar

    MedBytes

    MedBytes

    Medbytes Cards Listing
    Hi, can I help?
    Chat SupportX
    Support Team
    Hello, how can I help you today?
    Please select one of the below options.

    Find Information

    Unable to Login or Register

    Want to share feedback